I-Mab said on Wednesday it has agreed to divest its operations and assets in China as part of its strategy to become a U.S.-focused biotech firm, sending the company s shares up nearly 11% in.
I-Mab said on Wednesday it has agreed to divest its operations and assets in China as part of its strategy to become a U.S.-focused biotech firm, sending the company s shares up nearly 11% in. -February 07, 2024 at 11:32 am EST
- MarketScreener